Article Type
Article
Changed
Fri, 03/08/2019 - 11:21
Display Headline
Should methotrexate be a first-line treatment for rheumatoid arthritis?
Author(s)
William S. Wilke, MD
Article PDF
media_ace9717_ccjm66_4-0207.pdf
Author and Disclosure Information

William S. Wilke, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic; associate editor, Cleveland Clinc Journal of Medicine

Issue
Cleveland Clinic Journal of Medicine - 66(4)
Publications
Cleveland Clinic Journal of Medicine
Page Number
207-208
Sections
1-Minute Consult
Author(s)
William S. Wilke, MD
Author(s)
William S. Wilke, MD
Author and Disclosure Information

William S. Wilke, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic; associate editor, Cleveland Clinc Journal of Medicine

Author and Disclosure Information

William S. Wilke, MD
Department of Rheumatic and Immunologic Diseases, Cleveland Clinic; associate editor, Cleveland Clinc Journal of Medicine

Article PDF
media_ace9717_ccjm66_4-0207.pdf
Article PDF
media_ace9717_ccjm66_4-0207.pdf
Issue
Cleveland Clinic Journal of Medicine - 66(4)
Issue
Cleveland Clinic Journal of Medicine - 66(4)
Page Number
207-208
Page Number
207-208
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Should methotrexate be a first-line treatment for rheumatoid arthritis?
Display Headline
Should methotrexate be a first-line treatment for rheumatoid arthritis?
Sections
1-Minute Consult
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media